Is There THC in CBD? It Depends on the Type

Every CBD product contains some amount of THC, or at least has the potential to, unless it is made from pure CBD isolate. The answer hinges on which of the three main product types you buy: isolate, broad-spectrum, or full-spectrum. Full-spectrum CBD oil deliberately retains THC at low levels, broad-spectrum is processed to strip THC out but doesn’t always succeed, and isolate is refined to contain nothing but CBD itself. The real-world picture is messier than those labels suggest, though, because independent testing routinely finds THC in products that claim to be THC-free.

The Three Product Types and What They Actually Contain

CBD oils fall into three categories based on how much of the original hemp plant’s chemistry they preserve. Full-spectrum products keep the full range of cannabinoids, terpenes, and other plant compounds found in the hemp extract, including THC at concentrations below the legal ceiling of 0.3% by dry weight. Broad-spectrum products go through additional processing to remove THC while theoretically retaining the other minor cannabinoids and terpenes. Isolate products are refined further still, stripping away everything except CBD in its pure crystalline form.¹

In practice, “broad-spectrum” and “THC-free” are not synonyms. The THC removal step varies by manufacturer and is not standardized. Some companies use chromatographic techniques that selectively pull out THC, while others rely on distillation or chemical processes that leave trace amounts behind. A 2025 study analyzing commercial CBD tinctures in the United States found that while all full-spectrum products tested contained both delta-9-THC and delta-8-THC (within the federal limit), two broad-spectrum tinctures also contained detectable delta-9-THC despite being marketed as THC-free.² So if your primary concern is avoiding THC entirely, even broad-spectrum products are not a guarantee.

How Much THC Is in Full-Spectrum CBD

Under United States federal law, hemp-derived CBD products can contain up to 0.3% total THC on a dry weight basis. That threshold, set by the 2018 Farm Bill, applies to both the acid form of THC (THCA, which is non-psychoactive) and the neutral form (delta-9-THC, which is psychoactive).³ That 0.3% cap sounds tiny, but the absolute amount of THC you consume depends on your dose. If you take a large amount of a full-spectrum oil daily, the milligrams of THC can add up.

A clinical trial illustrates this. Participants using a full-spectrum, high-CBD product took an average of about 35 mg of CBD per day, which came with roughly 0.8 mg of delta-9-THC per day. After four weeks, half of the participants tested positive for THC metabolites on a standard urine drug screen.⁴ That is a striking failure rate for a product that is legal and marketed as non-intoxicating. The THC-to-CBD ratio was very small, but repeated daily exposure allowed THC metabolites to accumulate in the body.

Drug Testing and Why It Matters

The drug-test question is the one that keeps most people up at night. Standard workplace urine screens look for THC-COOH, the main metabolite your body produces after processing THC, and they do not distinguish between THC from marijuana and THC from a legal hemp product. A separate study looking at vaporized CBD-dominant cannabis confirmed the same pattern: although pure CBD alone is unlikely to trigger a positive result, hemp products containing even low amounts of THC can produce a cannabis-positive urine test.⁵

The risk scales with your dose, your body composition, and how long you have been using the product. THC is fat-soluble, so it accumulates in adipose tissue over time. Someone taking a modest dose of full-spectrum CBD for a few days is far less likely to test positive than someone who has been taking a high dose daily for a month. If you face regular drug screening for work, athletics, or legal compliance, isolate is the only product type that reliably avoids this problem. Broad-spectrum reduces the risk substantially but, as the label-accuracy data suggests, does not eliminate it.

The Label Accuracy Problem

Even if you choose your product type carefully, you are partly at the mercy of the manufacturer’s quality control. The CBD market has a well-documented labeling problem. One analysis of nonprescription CBD consumer products found THC in roughly 55% of oils tested, 24% of aqueous (water-based) products, and 71% of “other” product formats like topicals and capsules.⁶ Some of these products were not labeled as containing any THC at all.

The CBD concentration itself is often wrong, too. The 2025 tincture study found that 12 out of 18 samples had inaccurately labeled CBD concentrations, and there was a significant difference in label accuracy between broad-spectrum and full-spectrum products.² The issue is not limited to THC content specifically. It extends to whether the product contains what the label says it does, period. In a loosely regulated market, third-party certificates of analysis (COAs) from independent labs are the closest thing to a safety net. If a company does not publish current COAs on their website, that is a red flag worth taking seriously.

Delta-8 THC and Other Minor Isomers

When people ask about THC in CBD products, they usually mean delta-9-THC, the compound responsible for the classic marijuana high. But other THC isomers can show up too, and delta-8-THC is the most common one. Delta-8 occurs naturally in cannabis at very low levels, but it can also be produced synthetically from CBD through acid-catalyzed chemical reactions. This process has fueled a booming delta-8 market, and trace amounts of delta-8 sometimes appear in CBD products as a byproduct of processing.

Analysis of commercial delta-8-THC products has found various impurities, including unidentified cannabinoid isomers that share similar molecular structures with THC and CBD but differ in ways that standard lab tests may not easily distinguish.⁷ These unknown compounds are one reason regulators and researchers have raised concerns about the semi-synthetic cannabinoid market. The 2025 tincture study found delta-8-THC in all full-spectrum products tested, alongside delta-9-THC.² Whether the amounts are large enough to have any biological effect is uncertain, but they do count toward what is “in” your CBD product.

Can CBD Turn Into THC on Its Own

There is a persistent claim that CBD converts to THC inside your body, particularly in the acidic environment of the stomach. The chemistry behind this is not fictional. CBD can indeed be converted to delta-9-THC, delta-8-THC, and other isomers under laboratory conditions using strong acid catalysts.⁸ This reaction has been studied since the 1940s, and the specific products depend on which acid is used and the temperature of the reaction. One acid catalyst favors delta-8-THC formation, while another tends to produce delta-9-THC.⁹

However, the conditions required are far harsher than what exists in a human stomach. The experiments that demonstrate this conversion use concentrated sulfuric acid, boron trifluoride, or similarly aggressive reagents at controlled temperatures.¹⁰ Stomach acid is mild by comparison. Scientific reviews of this question have generally concluded that while the chemical pathway exists in a flask, there is no convincing evidence that it happens to a meaningful degree inside the human body. The THC detected in people who use CBD products is far more likely to come from THC that was already in the product than from any in-body conversion.

How Storage Affects THC Levels Over Time

CBD products do not stay chemically frozen on the shelf. Both CBD and THC degrade over time, and the rate depends heavily on storage conditions. Heat, light, and oxygen all accelerate degradation. A study of CBD stored in sunflower oil solutions and as solid powder found that degraded samples contained cannabinol (CBN), a breakdown product of THC, though the researchers noted that any delta-9-THC produced during degradation could have been present at levels below their instrument’s detection threshold.¹¹

Light exposure is the biggest enemy. Research on CBD dissolved in MCT oil found that dark storage caused only about a 5.5% loss of CBD over six months, while storage in a clear vial under light led to nearly a 37% reduction over the same period.¹² Separate work on cannabis resin showed that the degradation rate of both CBD and THC increases sharply at higher temperatures, especially above 70°C, and that acidic conditions speed the process further.¹³ The practical takeaway is straightforward: store your CBD in a cool, dark place, and don’t keep it for years expecting it to stay potent. As the product degrades, the ratio of cannabinoids shifts in unpredictable ways.

The Entourage Effect and Why Some Products Keep THC In

Full-spectrum products exist for a reason. Many CBD users and some researchers believe that the various cannabinoids, terpenes, and other plant compounds in hemp work better together than any single compound does alone. This idea is called the entourage effect. The evidence is still debated, but there are suggestive findings. A mouse study found that CBD combined with a low dose of delta-9-THC (at a 20:3 CBD-to-THC ratio) produced significantly greater anticonvulsant effects than either compound alone.¹⁴

That is an animal study, and the results don’t automatically translate to humans buying an oil online. But it helps explain why many manufacturers intentionally keep THC in their formulations rather than removing it. The pharmacokinetics also differ between product types. Research comparing how the body absorbs CBD from isolate, broad-spectrum, and full-spectrum oils found measurably different absorption profiles, though variations in formulation and delivery method (capsules versus liquids, for instance) also play a large role.¹⁵ Some consumers report better results from full-spectrum products, though separating genuine pharmacological synergy from placebo expectations is difficult without more controlled human trials.

CBD, THC, and Driving

One question that comes up less often but matters quite a bit is whether the THC in CBD products could impair you. At the concentrations found in legal hemp-derived CBD, the answer for most people is no: sub-milligram amounts of THC are not going to produce a noticeable high. But it is worth knowing that CBD itself does not cancel out THC’s impairing effects. A controlled study found that vaporized cannabis with equal parts THC and CBD still impaired driving performance (specifically, lane weaving and divided attention) just as much as THC alone, and on some cognitive tasks the impairment was actually worse with the combined product.¹⁶ That study used much higher THC doses than you would get from a CBD oil, but it undercuts the popular belief that CBD is a kind of antidote to THC intoxication. If you accidentally take a product with more THC than expected, CBD in the same product will not protect your driving ability.

Pets and THC Sensitivity

CBD products have become popular for dogs and cats, and the THC question takes on extra urgency here because dogs are significantly more sensitive to THC than humans are. Dogs produce additional active THC metabolites that humans do not, which may explain why they experience a wider and longer-lasting range of clinical signs from THC exposure.¹⁷ A dose of THC that would be trivial for a person could be clinically significant for a small dog. If you are giving your pet a CBD product, the distinction between isolate and full-spectrum becomes more than a personal preference. Veterinary guidance generally leans toward products with verified zero or near-zero THC content, and a current third-party COA is even more important for pet products than for human ones.

What to Look for When You Buy

Navigating the CBD market comes down to a few practical steps. First, decide whether you want to avoid THC completely or are comfortable with trace amounts. If you must avoid it, choose a CBD isolate product from a company that publishes batch-specific third-party test results. If you are open to trace THC and want the potential benefits of a broader cannabinoid profile, full-spectrum products are a reasonable choice, but understand the drug-testing risk that comes with them.

Second, look at the certificate of analysis. A reputable COA will list concentrations of multiple cannabinoids, including delta-9-THC, delta-8-THC, CBD, CBN, and CBG at minimum. Laboratories using sensitive methods can detect THC at extremely low concentrations, down to 0.001 mg per gram of product.¹⁸ If a COA does not show individual cannabinoid results, or if it is more than a few months old, treat it with skepticism. The fact that two-thirds of CBD products in one study had inaccurate CBD labels tells you how much trust to place in a label alone.²

Third, store whatever you buy properly. Keep it in a dark container in a cool place, and don’t hold onto a bottle for over a year expecting it to perform the same as when you opened it. Degradation changes the cannabinoid profile in ways you will not be able to see or taste, and the label that was accurate at the time of manufacture becomes progressively less reliable.